Medical Disorders
Resources
Basic InformationLookupsLatest News
AHA News: Lowering Blood Pressure May Prevent New Brain Lesions in Older PeopleBladder Drug Can Cause Eye Damage: StudyGood News, Bad News on Concussions in High School SportsSteroid Shots for Painful Joints May Make Matters WorseHealth Tip: Broken Toe CareChildhood Risk Factors Can Predict Adult ObesityHealth Tip: Gum Disease Risk FactorsPut Safety First When Planning to Pack Food-to-GoA Parent's Guide to Managing Kids' Asthma During the FallVision Problems Strike More Than 2 Billion GloballyLight Smoking Causes More Lung Damage Than Once Suspected: StudyHealth Tip: Choking First AidBy Mid-Century, Heat Waves Could Cover Far Bigger AreasGet Vaccinated Before Flu Takes Hold: CDCClose to 1,300 Cases of Vaping-Linked Illness Now IdentifiedMore Years of Football, Higher Odds for Brain Disease LaterPain Relief: When to Use Cold, When to Use HeatAHA News: High Triglycerides Caused a Diet Change – at Age 10Humans May Possess Ability to Regrow CartilageHealth Tip: Recognizing Bedbug Bites'Smartphone Slouching' More Serious Than It SoundsAHA News: What's Your Sense of Purpose? The Answer May Affect Your HealthDeep Brain Stimulation May Relieve Ringing in the Ears: StudyWhat Are the Risks of Pain Relief Alternatives to Opioids?Many ICU Admissions May Be Preventable, Large Study SuggestsCause of Paralyzing Illness in Kids Remains ElusiveFlu Season Is Coming: Here's How to Protect YourselfSinus Infections: What You Need to KnowFewer Teeth, Higher Risk of Heart Disease?Fungal Invasion May Drive Some Pancreatic CancersHealth Tip: Lowering Your Resting Heart RateCan Your Eating Habits Keep Alzheimer's at Bay?Prescription Opioids Linked to Poor Outcomes in Kidney PatientsCases of Serious Vaping-Linked Lung Injury Now Top 1,000Organic Chicken Less Likely to Harbor a Dangerous 'Superbug'Running the Numbers on High Blood PressureIs Partial Hip Replacement Often the Better Option?'Toxic Fumes' May Be Driving Vaping-Linked Lung Illnesses'Nerve-Release' Surgery Helped Ease One Man's Tough MigrainesCould Vitamin C Infusions Save Patients With Sepsis?Some May Be Vulnerable to Severe Skin Reaction While Using Gout DrugThree-Drug Inhaler May Be an Advance for Asthma PatientsCab Drivers Breathe in Way Too Much Smog'Alarming' Number of Lupus Patients Use Opioids for Pain: StudyChildhood TB Shot May Offer Long-Term Protection from Lung CancerMavyret Approved as 8-Week Treatment for Hep C, Compensated CirrhosisMany Americans With Rheumatic Disease Face Financial, Lifestyle PressuresRadiation for Head and Neck Cancer May Cause Problems Years LaterHealth Tip: Reducing EyestrainSticking to One Sport Could Up Injuries Among Teen Athletes
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Xpovio With Dexamethasone Approved for Refractory Multiple Myeloma


HealthDay News
Updated: Jul 10th 2019

new article illustration

TUESDAY, July 9, 2019 (HealthDay News) -- Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma, the U.S. Food and Drug Administration announced last week.

The drug combination was granted accelerated approval for patients whose disease remains resistant to other treatments, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

Approval was based on data from 83 patients with relapsed refractory multiple myeloma who received Xpovio and dexamethasone. Researchers found an overall response rate of 25.3 percent at the end of the study. Median time to first response was four weeks and ranged from one to 10 weeks. Median response duration was 3.8 months. The FDA notes that approval was also based on information from an ongoing, randomized trial in patients with multiple myeloma, but additional clinical trials are required to verify the clinical benefit of Xpovio.

Commonly reported side effects with the drug combination include leukopenia, low neutrophil count, neutropenia, thrombocytopenia, and anemia. Vomiting, nausea, fatigue, diarrhea, fever, decreased appetite, weight loss, constipation, upper respiratory tract infections, and hyponatremia were also reported. Clinicians should monitor patients being treated with Xpovio and dexamethasone for low blood counts, platelets, and sodium levels; they should optimize patients' hydration status, blood counts, and other medications to avoid dizziness or confusion. Patients should be advised to not take Xpovio with medications that could cause dizziness or confusion.

Approval of Xpovio was granted to Karyopharm Therapeutics.

More Information




Facebook

Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.

 


powered by centersite dot net